Olutasidenib

CAS : 1887014-12-1

Ref. 3D-MAD01412

Informations sur le produit

• Nom: Olutasidenib
• Marque: Biosynth
• Description: Olutasidenib is a molecule that inhibits the platelet-derived growth factor receptor alpha (PDGFRα) and is being investigated as a treatment for chronic myeloid leukemia (CML). Olutasidenib binds to PDGFRα, which prevents the activation of the receptor. This blocks the signaling that leads to tumor progression and inhibits tumor growth. Olutasidenib has been shown to be safe in phase I/II trials, with no serious adverse effects reported.

Propriétés chimiques

• Masse moléculaire: 354.79 g/mol
• Formule: C₁₈H₁₅ClN₄O₂
• Degré de pureté: Min. 95%